Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis.
Yong Il LeeYe Hyun ParkSoo Jung ParkTae Il KimByung Chang KimJae Hee CheonPublished in: Gut and liver (2021)
In our study, infliximab and adalimumab had similar treatment efficacy and longterm outcomes in biologic-naïve patients with moderate to severe UC.